G |
N/A |
N/A |
HepG2 |
25 μg mL−1
|
UPLC-MS |
Arginine and proline |
Membrane damage |
286
|
Purine |
Protein damage |
Glycophospholipid |
Urea cycle |
G |
2000 × 2000 × 12 |
N/A |
RAW 264.7 |
50, 100 μg mL−1
|
HPLC-MS |
GSH |
Mitochondrial membrane potential |
287
|
1, 3 h |
Sphingolipid |
CD36-dependent response |
CoA |
Purine |
G |
N/A |
N/A |
HaCaT |
5 μg mL−1
|
1H NMR |
Fumarate ↑ |
ROS generation |
291
|
168 h |
Glycerophosphocholine ↑ |
Mitochondrial damage |
Pyruvate ↓ |
Cell death |
Phosphocreatine ↓ |
Cell migration |
Phosphocholine ↓ |
G |
N/A |
Carboxyl |
A549 |
0.01, 0.1 μg mL−1
|
LC-MS |
Amino acid |
ROS generation |
292
|
48 h |
Organic acids |
Apoptosis |
Glycerophospholipid |
Glycerolipids |
GO |
N/A |
N/A |
HaCaT |
5 μg mL−1
|
1H NMR |
Fumarate ↓ |
ROS generation |
291
|
168 h |
Alanine ↑ |
Mitochondrial damage |
Pyruvate ↑ |
Cell death |
Phosphocreatine ↑ |
Cell migration |
Glycerophosphocholine ↑ |
GO |
N/A |
N/A |
MCF-7 |
20, 40, 60 μg mL−1
|
1H NMR |
Arginine |
Catabolism |
288
|
24 h |
Proline |
Therapeutic activity |
GSH |
TCA |
GO |
300 |
PEG |
Saos-2 |
75 μg mL−1
|
1H NMR |
Amino acid ↓ |
Proliferation delay |
293
|
24 h |
Taurine ↓ |
Oxidative stress |
Creatine ↓ |
Phosphocholine ↑ |
Nucleotide ↑ |
GO |
N/A |
N/A |
RLE-6TN |
10 μg cm−2
|
HPLC-MS/MS |
Amino acid |
Oxidative stress |
231
|
24 h |
FIA-MS/MS |
Biogenic amine |
Apoptosis |
Lipid |
GO |
N/A |
N/A |
NR8383 |
2.5, 5, 10 μg cm−2
|
HPLC-MS |
No significant alteration |
Oxidative stress |
243
|
24 h |
Mitochondrial dysfunction |
DNA damage |
Cell death |
GO |
500–5000 × 0.8–1.2 |
N/A |
Alga C. vulgaris
|
0.01–10 μg mL−1
|
GC-MS |
Alkanes, lysine, octadecadienoic acid and valine |
ROS generation |
294
|
96 h |
Oxidative stress |
MWCNT |
500–2000 × 8–15 × 3–5 |
None |
BEAS-2B |
2–39 μg mL−1
|
1H NMR |
Choline |
Oxidative stress |
295
|
Hydroxyl |
HepG2 |
24 h |
Betaine |
Inflammation |
Carboxyl |
Succinate |
Profibrosis |
DNA damage |
MWCNT |
[(1–3) or (0.05–0.2) 104 × 20–30 or 8–15] |
Hydroxyl |
BEAS-2B |
6–45 μg mL−1
|
1H NMR |
TCA |
Oxidative stress |
296
|
HepG2 |
24 h |
GSH |
Inflammation |
Amino acid |
Profibrosis |
DNA damage |
MWCNT |
846 × 11 |
N/A |
HBEC-3KT |
0.96, 1.92 μg cm−2
|
FT-MS/MS |
TG, SM, Cer, PE, Chol ↑ |
ROS generation |
297
|
2, 13 weeks |
Apoptosis |
SWCNT |
500–3000 × 1–2 |
Carboxyl |
Alga C. vulgaris
|
0.01–10 μg mL−1
|
GC-MS |
Alkanes, lysine, octadecadienoic acid and valine |
ROS generation |
294
|
96 h |
Oxidative stress |
CNT |
N/A |
Carboxyl |
A549 |
0.01, 0.1 μg mL−1
|
LC-MS |
Amino acid |
Energy metabolism dysfunction |
292
|
48 h |
Organic acids |
ROS generation |
Glycerophospholipid |
Apoptosis |
Glycerolipids |
C60
|
100 |
Carboxyl |
A549 |
0.01, 0.1 μg mL−1
|
LC-MS |
Amino acid |
Energy metabolism dysfunction |
292
|
48 h |
Organic acids |
Glycerophospholipid |
Glycerolipids |
C60
|
120–150 |
N/A |
Alga S. obliquus
|
0.1, 1 μg mL−1
|
GC-Q-TOF-MS |
TCA |
Growth inhibition |
298
|
168 h |
Sucrose, d-glucose, malic acid ↑ |
Photosynthesis decrease |
Cblack
|
30–50 |
N/A |
A549 |
70 μg mL−1
|
UHPLC-Q-TOF-MS |
TCA ↑ |
Inflammation |
289
|
48 h |
Alanine |
Oxidative stress |
Aspartate |
Energy and signalling pathway disruption |
Glutamate |
Apoptosis |
Histidine ↑ |
Cblack
|
14 |
None |
EA.hy926 |
0.001–1 μg mL−1
|
GC-MS |
Amino acid |
Enhanced cell proliferation |
299
|
Benzo[a]pyrene |
72 h |
Organic acid |
Cell motility |
Fatty acid |
Cell migration increase |
Ccellulose
|
2–40 |
N/A |
NG97 |
10, 100 μg mL−1
|
LC-MS |
Fatty acid |
Cell viability |
300
|
6 h |
Metabolic activity disruption |
Cyclodextrin |
0.5–1 |
Folate |
MDA-MB-231 |
1 : 16 (v/v) |
LC-Q-TOF-MS |
Hexose metabolism |
Apoptosis |
301
|
24 h |
Glycolysis |
TCA |
Glycyrrhizin (GL-BSA-Lut-NPs) |
225.3 |
Luteolin |
Bel-7402 |
0.375, 0.75, 1.25, 2.5, 5 mg mL−1
|
1H NMR |
Lactate, 3-hydroxybutyrate, lipid, tyrosine, and β-glucose↓ |
Antitumor effect |
302
|
BSA |
24 h |
Glutamate, asparagine, choline, and creatine ↑ |
Apoptosis |